The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.
TBD
Lionheart Health, Inc. is focused on reversing aging inside and out 20 years with a focused and clinically proven patented bioelectric protein expression technology platform. Klotho and stem cell homing are key components for whole body regeneration.
MOGL: AI Powered Influencer MarketingMOGL is revolutionizing the $180bn influencer space by optimizing how brands reach their target audience through influencer marketing.The company’s AI powered platform matches brands with athlete influencers in seconds and, leveraging 1st party data, enables them to invest in the best performing assets and influencers. After doubling YoY revenue, we have now grown 72% and 83% MoM to start the year and have reached 42% of 2024 revenue. We’re ahead of pace to achieve $1.5m ARR by the end of the year and be profitable in 20
Hiring is broken—understaffed teams and vague job descriptions lead to costly mis-hires. InterviewByte’s AI Interviewers engage hiring managers and candidates, delivering clear, data-driven rankings without high costs. Backed by leaders at Stripe, Palo Alto Networks, and AWS, they have active pilots and top ATS partnerships. The CEO and CPO Founder, a second-time founder with leadership at Citi, S&P, Oracle, and more. She built our MVP, secured key partnerships, and assembled a powerhouse team.
Axio is designed to support your education, career advancement, and well-being. By getting to know you, Axio personalizes your learning and professional development, organizes your tasks, and boosts your productivity.
Sen-Jam Pharmaceutical is revolutionizing inflammation management with a patented platform of combination therapeutics designed to act preemptively. With a focus on high-impact markets—respiratory illness, alcohol hangover, and opioid withdrawal—Sen-Jam delivers scalable, de-risked assets poised for rapid commercialization. Their mission: to shift pharma from sick care to proactive health preservation.